Hypothesis: is accumulation of a furan dicarboxylic acid (3-carboxy-4- methyl-5-propyl-2-furanpropanoic acid) related to the neurological abnormalities in patients with renal failure?
The Plasma concentrations of a lipophilic furan dicarboxylic acid (3- carboxy-4-methyl-5-propyl-2-fluranpropanoic acid; 5-propyl FPA), which is highly bound to albumin and not removed by haemodialysis, have been measured in patients with renal impairment who were not dialysis dependent or who were t...
Autores principales: | Costigan, MG, Callaghan, C, Lindup, W |
---|---|
Formato: | Journal article |
Lenguaje: | English |
Publicado: |
1996
|
Ejemplares similares
-
Relationship of plasma 3‐carboxy‐4‐methyl‐5‐propyl‐2‐furanpropanoic acid concentration with OATP1B activity in patients with chronic kidney disease
por: Hiroyuki Ono, et al.
Publicado: (2024-02-01) -
Circulating 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) levels are associated with hyperglycemia and β cell dysfunction in a Chinese population
por: Shan Zhang, et al.
Publicado: (2017-06-01) -
3-Carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) induces cell death through ferroptosis and acts as a trigger of apoptosis in kidney cells
por: Jung Sun Park, et al.
Publicado: (2023-02-01) -
Direct synthesis of furan-2,5-dicarboxylic acid monoamides
por: Róbert Fischer, et al.
Publicado: (2015-09-01) -
Process Analysis of Furan Dicarboxylic Acid Production from Lignocellulose Biomass
por: Dang Saebea, et al.
Publicado: (2024-07-01)